Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Entities / Petrelintide
Other

Petrelintide

Tracked across 1 events · 19 articles · First seen May 27, 2026 · Last active Jun 01, 2026

Sentiment
65
Attention
6
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
6 65
Tech
Genentech Presents Positive Obesity Drug Data
F. Hoffmann-La Roche — Genentech, a member of the Roche Group, announced new data from its obesity portfolio will be presented at the 2026 Scientific Sessions of the American Diabetes Association. The data highlights significant…
Impact: Petrelintide is an investigational human amylin analog that demonstrated efficacy and a compelling tolerability profile in Phase II trials for weight management, and is also advancing to Phase III development.
May 27, 2026 · 19 articles
NEWSDESK
Track Petrelintide live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.